API maker Fleming Laboratories raises Rs 110 cr from PE fund InvAscent
Pfizer and Mylan wiped their hands of another EpiPen antitrust suit.
Fleming Laboratories has been banned from shipping APIs to the US by the FDA which says its manufacturing plant in Nawabpet, Telangana in India is not up to code.
Fleming Laboratories Ltd. On FDA Import Alert List
The US health regulator has issued an import alert for the drugs and drug products manufactured by Hyderabad-based Fleming Laboratories at its Nawabpet facility in Medak district.
As the country is facing non-availability of life-saving drug D-Penicillamine, prescribed for Wilson’s disease, Panacea Biotec, which is one of the manufacturers of D-Penicillamine capsules, has taken several initiatives to make the drug available to needy patients including launching a website and forming a Whatsapp Group.
Two Chinese and two Indian companies have been banned from importing APIs to the US – one manufacturer says it’s making GMP compliance a “priority.”